Amy Abernethy

Amy Abernethy is president of clinical research platforms at Alphabet’s Verily, where she has responsibility for the company’s Baseline program and other initiatives to support clinical trials and real-world evidence studies. Before joining Verily, Abernethy was principal deputy commissioner and acting chief information officer of the US Food and Drug Administration. Prior roles include serving as chief medical officer and chief scientific officer of Flatiron Health and multiple roles at Duke University, where she was professor of medicine.